Chen Li-Feng, Yang Yang, Yu Xin-Guang, Gui Qiu-Ping, Bu Bo, Xu Bai-Nan, Zhou Ding-Biao
Department of Neurosurgery, The Chinese PLA General Hospital, the No.28 Fuxing Road, Haidian District, Beijing, 100853, China.
Acta Neurochir (Wien). 2014 Jun;156(6):1105-14. doi: 10.1007/s00701-014-2051-7. Epub 2014 Mar 15.
The trigeminal schwannoma is the second most common intracranial schwannoma. Their proximity to the critical skull base neural and vascular structures increases the complexity of surgical treatment. The aim of this study was to better understand the surgical approaches and the prognosis, as well as to assess the optimum therapeutic schedule.
This was a retrospective study of 55 patients with trigeminal schwannomas who visited our department between Jan 2007 and Jan 2012. We analyzed the clinical and radiological presentation, tumor characteristics, surgical approaches, the prognosis.
The patients were 30 women and 25 men of mean age 36 years (range, 6-66 years) who received postoperative neurological and neuroradiological follow-up. The tumor was located in the middle fossa (type A) in 13 cases, in the posterior fossa (type B) in ten cases, in the middle and posterior fossae (type C) in 21 cases, and in the branches of the trigeminal nerve (type D) in 11 cases. The most common symptom was facial hypesthesia or numbness in 36 patients (65 %) . Total and nearly total tumor resection was achieved in 51 cases (93 %). Three patients (5 %) had worsening of preexisting deficits and there was no perioperative mortality. With an average follow-up period of 35 months, facial hypesthesia persisted in 26 patients (72 %),and improved in ten patients (28 %). Facial pain was relieved in 11 patients (100 %). There has been a recurrence in one case (2 %) and all patients resumed independent and social reintegration.
This study demonstrates radical surgery with excellent neurological outcomes is the primary treatment of trigeminal schwannomas. Appropriate selection of surgical approach according to tumor types is highly important and necessary. The preoperative facial pain could be relieved, hypesthesia frequently remains or could even be worsened after surgery.
三叉神经鞘瘤是第二常见的颅内神经鞘瘤。其靠近颅底关键神经和血管结构,增加了手术治疗的复杂性。本研究旨在更好地了解手术方法和预后,并评估最佳治疗方案。
这是一项对2007年1月至2012年1月期间来我院就诊的55例三叉神经鞘瘤患者的回顾性研究。我们分析了临床和影像学表现、肿瘤特征、手术方法及预后。
患者中女性30例,男性25例,平均年龄36岁(范围6 - 66岁),术后接受了神经学和神经放射学随访。肿瘤位于中颅窝(A型)13例,后颅窝(B型)10例,中后颅窝(C型)21例,三叉神经分支(D型)11例。最常见症状为面部感觉减退或麻木,共36例(65%)。51例(93%)实现了肿瘤全切或近全切。3例(5%)患者原有神经功能缺损加重,无围手术期死亡。平均随访35个月,26例(72%)患者面部感觉减退持续存在,10例(28%)有所改善。11例(100%)患者面部疼痛缓解。1例(2%)复发,所有患者均恢复独立生活并重新融入社会。
本研究表明,根治性手术及良好的神经学预后是三叉神经鞘瘤的主要治疗方法。根据肿瘤类型合理选择手术入路非常重要且必要。术前面部疼痛可缓解,但术后感觉减退常持续存在甚至可能加重。